TD Cowen analyst Moshe Orenbuch lowered the firm’s price target on Affirm (AFRM) to $95 from $110 and keeps a Buy rating on the shares. The firm reported a strong Q2 beat on strong revenue and margins and the company was clear that they believe the new products and strategies will continue to drive high revenue growth and margins.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AFRM: